Amarillo Biosciences, Inc.

Amarillo Biosciences, Inc., (ABI), is a dynamic marketplace focused biopharmaceutical company developing low dose oral and topical interferon alpha. We are directing our research at the treatment of fibromyalgia syndrome (FMS), Sjögren's syndrome hepatitis B, hepatitis C, and a variety of skin diseases. The company is also in early stage development of interferon gamma and tumor necrosis factor alpha for oral and topical administration.
We are competent communicators and welcome the chance to talk about our research and our business.

Activity:

- Research & Development

Product / Technology type(s) covered:

- Bio
- Pharmaceuticals / Therapeutics

Therapeutic targets:

- Cancer
- Dermatology
- Infectious Diseases

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: